* Download comes with a free subscription to our newsletter. You can unsubscribe any time. You will not get duplicate emails if you download more than one report.
The immunotherapy cocktail consists of an antibody (PD-1) that prevents melanoma cells from escaping immune surveillance and another antibody (CTLA-4) which enhance the ability of immune cells to kill cancer cells.